Advancements in prospective real-world research have opened a world in which organizations can articulate the value of their medicines more effectively and ultimately bring life-saving treatments to market faster. In this webinar, we talk with Novartis’s Adrian Cassidy and Memorial Sloan Kettering Cancer Center’s Joseph Lengfellner about validating and scaling clinical research innovations; expanding patient access through innovative study design; and establishing partnerships with tech, pharma and academic institutions to create change.
You’ll learn:
- How to leverage digital innovations to generate evidence
- Critical success factors in pragmatic and innovative evidence generation
- How differentiated real-world data can serve as a competitive advantage for prospective research
Add insights to your inbox
We’ll send you content you’ll want to read – and put to use.
